Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...

書誌詳細
主要な著者:	Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW
フォーマット:	Journal article
言語:	English
出版事項:	Massachusetts Medical Society 2019

類似資料

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
著者:: Llanos-Cuentas, A, 等
出版事項: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
著者:: St Jean, PL, 等
出版事項: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
著者:: Watson, JA, 等
出版事項: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
著者:: Watson, JA, 等
出版事項: (2024)

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
著者:: Mark M Fukuda, 等
出版事項: (2017-01-01)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
著者:: Stephan Duparc, 等
出版事項: (2020-03-01)

Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
著者:: Rueangweerayut, R, 等
出版事項: (2017)

Tafenoquine — a radical improvement?
著者:: White, N
出版事項: (2019)

The antimalarial activity of tafenoquine in falciparum malaria
著者:: White, NJ
出版事項: (2023)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
著者:: Raman Sharma, 等
出版事項: (2024-05-01)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
著者:: Baird, J
出版事項: (2018)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
著者:: Watson, JA, 等
出版事項: (2021)

Tafenoquine for children: a step towards implementation
著者:: Commons, RJ, 等
出版事項: (2021)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
著者:: Pengfei She, 等
出版事項: (2023-12-01)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
著者:: Geoffrey W. Birrell, 等
出版事項: (2022-11-01)

Tafenoquine and G6PD: a primer for clinicians
著者:: Chu, CS, 等
出版事項: (2019)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
著者:: Watson, J, 等
出版事項: (2019)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
著者:: Luisa Oliveira Santos, 等
出版事項: (2024-08-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
著者:: James A Watson, 等
出版事項: (2022-12-01)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
著者:: Baird, JK
出版事項: (2021)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
著者:: James A Watson, 等
出版事項: (2024-02-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
著者:: Römsing, S, 等
出版事項: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
著者:: Romsing, S, 等
出版事項: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
著者:: Watson, J, 等
出版事項: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
著者:: James Watson, 等
出版事項: (2018-04-01)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
著者:: Commons, RJ, 等
出版事項: (2020)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
著者:: Ebstie YA, 等
出版事項: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
著者:: Amit Sharma, 等
出版事項: (2021-02-01)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
著者:: Markus MB
出版事項: (2021-09-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
著者:: Leonardo J. M. Carvalho, 等
出版事項: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
著者:: Christensen, Peter, 等
出版事項: (2024)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
著者:: Kenworthy David, 等
出版事項: (2011-07-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
著者:: Karen Kemirembe, 等
出版事項: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
著者:: Zeid A. ALOthman, 等
出版事項: (2020-01-01)

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
著者:: Luis A. Marcos, 等
出版事項: (2022-01-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
著者:: Raman Sharma, 等
出版事項: (2024-02-01)

Phytochemical Screening and Antimicrobial Activity Evaluation of Selected Medicinal Plants in Ethiopia
著者:: Dubale S, 等
出版事項: (2023-02-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
著者:: Hale, B, 等
出版事項: (2003)

Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
著者:: Sayyed Ibrahim Shah, 等
出版事項: (2022-08-01)

Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised Patient
著者:: Prithiv J. Prasad, 等
出版事項: (2022-09-01)